Brief: A1M Pharma signs agreement with Swedish CRO partner
Oct 24 (Reuters) - A1M PHARMA AB A1M.ST :
* A1M PHARMA INITIATES COLLABORATION WITH SWEDISH CRO
PARTNER FOR CLINICAL STUDIES
* SIGNED AGREEMENT WITH SWEDISH CONTRACT RESEARCH
ORGANIZATION CLINICAL TRIALS CONSULTANTS
Source text for Eikon: ID:nBQN5SWdjn
Further company coverage: A1M.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover